|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.23 EUR | -0.33% |
|
+0.55% | -7.85% |
| 07-10 | Sanofi Receives Fda Approval for Subcutaneous Sarclisa Escena Administered Via On-Body Injector | CI |
| 07-10 | Sanofi Wins US FDA Approval for Subcutaneous Sarclisa Escena in Multiple Myeloma | MT |
EPS & Dividend: Sanofi
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.12 | 4.254 | 4.506 | 4.831 |
| Rate of return | 3.76% | 3.96% | 4.19% | 4.18% | 4.98% | 5.58% | 5.91% | 6.34% |
| EPS 2 | 4.97 | 5.37 | 4.31 | 4.59 | 6.4 | 6.626 | 7.214 | 8.497 |
| Distribution rate | 67% | 66.3% | 87.2% | 85.4% | 64.4% | 64.2% | 62.5% | 56.9% |
| Reference price 2 | 88.58 | 89.84 | 89.76 | 93.74 | 82.72 | 76.23 | 76.23 | 76.23 |
| Nbr of stocks (in thousands) | 1,255,293 | 1,254,060 | 1,253,891 | 1,247,793 | 1,216,810 | 1,200,220 | - | - |
| Announcement Date | 04/02/22 | 03/02/23 | 01/02/24 | 30/01/25 | 29/01/26 | - | - | - |
Past dividends: Sanofi
| 05/05/2026 | Ex-dividend date - 4.12 EUR | 08:00 |
Upcoming Events: Sanofi
| 30/07/2026 | Earnings release | Q2 2026 | |
| 30/07/2026 | Earnings presentation | 15:00 | |
| 30/10/2026 | Earnings release | Q3 2026 | |
| 30/10/2026 | Earnings presentation | 16:00 |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 5.56% | 5.89% | 11.54x | 1.22x | 2.15x | |
| 0.56% | 0.62% | 35.49x | 21.56x | 12.92x | |
| 2.06% | 2.16% | 27.65x | 6.95x | 6.35x | |
| 2.74% | 2.89% | 30.17x | 1346.43x | 7.39x | |
| 2.98% | 3.06% | 17.88x | 6.64x | 4.44x | |
| 2.86% | 2.95% | 21.53x | 6.42x | 5.52x | |
| 1.86% | 1.97% | 22.38x | 5.23x | 4.7x | |
| 3.55% | 3.45% | 14.08x | 6.2x | 5.27x | |
| 2.77% | 2.93% | 23.79x | 18.25x | 6.31x | |
| 2.41% | 2.49% | -47.8x | 8.43x | 5.8x | |
| Average | 2.74% | 2.84% | 15.67x | 142.73x | 6.08x | |
| Weighted average by Cap. | 2.08% | 2.17% | 23.70x | 171.03x | 7.80x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition